Fundraising Fox

Jeff Parker

Founder

Founder at Parkervision

Jacksonville, Florida, United States

FoundedParkervision

About

Jeff Parker is co-founder, President, and CEO of Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP), a clinical-stage biopharmaceutical company, having served as Managing Partner and Director since February 2018 prior to its IPO. He previously was President and CEO of Dipexium Pharmaceuticals (Nasdaq: DPRX) until its $69 million merger with PLx Pharma Inc., served as a board member of Abeona Therapeutics and as President and board member of MacroChem, and held executive roles at Bioenvision, Inc. Parker began his career as a certified public accountant at Ernst & Whinney LLP and later practiced corporate law at Paul Hastings LLP; he holds a B.S. in Business Administration from Bucknell University and a law degree from Albany Law School of Union University.

Founder at Parkervision

Co-founders at Parkervision

JP
Jeffrey ParkerExecutive Officer, Director

Experience

  1. Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP)President and Chief Executive Officercurrent2017 β€” presentNew York City Metropolitan Area
  2. Digital Prime TechnologiesChairmancurrent2019 β€” presentNew York City Metropolitan Area
  3. Ameri Holdings, Inc.Chairman of the Board of Directors2018 β€” 2019
  4. PLx Pharma Inc.Director2017
  5. Dipexium PharmaceuticalsPresident & CEO, Director2010 β€” 2017
  6. Access Pharmaceuticals, Inc.Director2007 β€” 2010New York, New York
  7. MacroChem CorporationPresident & Director2007 β€” 2009New York, New York
  8. Bioenvision, Inc. (Nasdaq: BIVN)Executive Vice President, CFO and General Counsel2002 β€” 2007New York, New York
  9. Paul, Hastings, Janofsky & Walker LLPCorporate Attorney1994 β€” 2002
  10. Ernst & Young LLPSenior Auditor1988 β€” 1991

Skills & more

Mergers4Licensing11Contract Negotiation7Corporate Finance20IPO25Biotechnology8Pharmaceuticals1Joint Ventures5Corporate Governance6Private Equity5Due Diligence15Intellectual Property2
+12 moreRestructuringVenture CapitalPrivate PlacementsDivestituresCapital MarketsStart-upsCorporate LawInvestor RelationsNegotiationStrategic PlanningStrategy DevelopmentStrategy

Languages Italian

  • CPA, JD

From Jeff's professional profile.

Frequently asked questions

Who is Jeff Parker?
Jeff Parker is co-founder, President, and CEO of Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP), a clinical-stage biopharmaceutical company, having served as Managing Partner and Director since February 2018 prior to its IPO. He previously was President and CEO of Dipexium Pharmaceuticals (Nasdaq: DPRX) until its $69 million merger with PLx Pharma Inc., served as a board member of Abeona Therapeutics and as President and board member of MacroChem, and held executive roles at Bioenvision, Inc. Parker began his career as a certified public accountant at Ernst & Whinney LLP and later practiced corporate law at Paul Hastings LLP; he holds a B.S. in Business Administration from Bucknell University and a law degree from Albany Law School of Union University.
Where does Jeff Parker work?
Jeff Parker is Founder of Parkervision.
What companies did Jeff Parker found?
Jeff Parker founded Parkervision.
Where did Jeff Parker go to school?
Jeff Parker studied at Albany Law School (JD, Law); Bucknell University (BSBA, Accounting and Business).

Same school

Shared employers